Latest filing published 05 Mar 2014 for Enanta Pharmaceuticals INC, €40k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +100.4%Entry US$19.96 · Close at T+365 US$39.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
TVM V Life Science Ventures GmbH & Co KG: trading record in brief
TVM V Life Science Ventures GmbH & Co KG is a declared insider at 4 companies; the most frequent names are Enanta Pharmaceuticals Inc, Sirtris Pharmaceuticals, Inc. and Pharmasset Inc. The record holds 44 filings, for trades running from 27 April 2007 to 4 March 2014.
The open-market side counts 2 purchases for €2.2M alongside 27 sales for €33.4M. The net balance comes to €31.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. So far in 2014, the count stands at no purchases and 27 sales.
The newest entry dates from 7 March 2014: an open-market sale of €2.5M, in Enanta Pharmaceuticals Inc. The latest purchase dates back some time: it was published 4,974 days ago, on 28 March 2013. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to TVM V Life Science Ventures GmbH & Co KG
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,402 shares@ US$38.8337Common StockSEC:0001012975-14-000138:0
- 1,874 shares@ US$38.8337Common StockSEC:0001012975-14-000138:1
- 5,795 shares@ US$38.8337Common StockSEC:0001012975-14-000138:2
- 66,506 shares@ US$38.8155Common StockSEC:0001012975-14-000138:3
- 88,877 shares@ US$38.8155Common StockSEC:0001012975-14-000138:4
- 274,880 shares@ US$38.8155Common StockSEC:0001012975-14-000138:5
- 27,297 shares@ US$38.9189Common StockSEC:0001012975-14-000121:0
- 36,478 shares@ US$38.9189Common StockSEC:0001012975-14-000121:1
- 112,826 shares@ US$38.9189Common StockSEC:0001012975-14-000121:2
- 8,283 shares@ US$39.9308Common StockSEC:0001012975-14-000121:3
- 11,069 shares@ US$39.9308Common StockSEC:0001012975-14-000121:4
- 34,237 shares@ US$39.9308Common StockSEC:0001012975-14-000121:5
- 1,218 shares@ US$40.00Common StockSEC:0001012975-14-000111:0
- 1,628 shares@ US$40.00Common StockSEC:0001012975-14-000111:1
- 5,034 shares@ US$40.00Common StockSEC:0001012975-14-000111:2
- 8,130 shares@ US$39.5093Common StockSEC:0001012975-14-000111:3
- 10,865 shares@ US$39.5093Common StockSEC:0001012975-14-000111:4
- 33,602 shares@ US$39.5093Common StockSEC:0001012975-14-000111:5
- 1,546 shares@ US$40.1853Common StockSEC:0001012975-14-000103:0
- 2,066 shares@ US$40.1853Common StockSEC:0001012975-14-000103:1
- 6,388 shares@ US$40.1853Common StockSEC:0001012975-14-000103:2
- 2,254,357 sharesCommon StockSEC:0001181431-13-036450:0
- 351,014 sharesCommon StockSEC:0001012975-13-000125:1
- 236,065 sharesCommon StockSEC:0001012975-13-000125:0
- 132,949 shares@ US$14.00Common StockSEC:0001012975-13-000125:6Canonical exit: 24 Jun 2013 (T+90)
25 of 38 declarations
